Abstract:Background: Following the primary endothelial injury caused by cellular or humoral immunities against donor antigens, some non-polymorphic tissue antigens of allograft, which are not normally exposed to immune system, become accessible. Autoimmunities against these antigens may be involved in further tissue injury. Autoimmunities to collagen-V and vimentin have been found to be associated with graft dysfunction in lung and heart transplantation respectively. Since both collagen-V and vimentin are widely expressed in most connective tissues, we hypothesize that autoimmunities against collagen-V and vimentin are also associated with failure of other allografts. Methods: 121 kidney recipients who either had biopsy-proved graft injury or experienced rejection episodes were included in this study. Serum samples selected before occurrence of rejection episodes or biopsy-proven graft injury were tested for collagen-V and vimentin antibodies using Luminex technique. Donor specific antibody (DSA) against HLA A, B, or DR were tested using Labscreen Single Antigen Beads. The association between graft outcome and allo- or auto-antibodies were analyzed retrospectively. Results: The percentages of patients with collagen-V, vimentin, and donor-HLA antibodies were 21%, 45%, and 35% respectively. Mean fluorescence intensity of antibodies against collagen-V (962±710), vimentin (849±642) were significantly lower than that of HLA antibodies (7273±5407). 64% of HLA DSA+ patients had collagen-V and/or vimentin antibodies, while 46% of autoantibodies positive patients had HLA-DSAs. Presence of autoantibodies seemed to be significantly associated with HLA-DSAs (p< 0.05). Graft survival analysis demonstrated that DSA and autoantibody double negative patients had the highest 5-yr graft survival rate (61%, ref.), followed by those with only HLA-DSA (55%, p>0.05%), only autoantibody (47%, p>0.05), and double positive patients (12%, p< 0.01).[Figure 1]After adjustment for other predictors of graft failure, multivariate Cox analysis confirmed that the difference of graft survival rates between double negative and double positive patients was statistically significant. Conclusion: Collagen-V & vimentin antibodies were detected at low titers but high frequencies in renal graft recipients. Survival analysis suggested a synergistic effect of HLA-DSA and autoantibodies. HLA-A, B, or DR DSA were only detected in 46% of autoantibody+ patients, which suggested that these DSAs were not the only cause of primary endothelial injury resulting in secondary autoantibody responses. Cellular immunities or other alloantibodies (HLA-C, DP, DQ, or MICA- specific) might be also involved. Further studies are required to determine: 1) the time course of autoantibody development and its association with allospecific humoral and/or cellular immunities; 2) whether collagen-V and vimentin antibodies exist in failed or rejected allografts (elution of antibody from biopsy tissue); 3) the association of autoantibodies with biopsy-proven graft injury, especially chronic injury such as interstitial fibrosis.

Contribution of B Cells and Antibody to Cardiac Allograft Vasculopathy

The Role of Alloantibody in the Development of Cardiac Allograft Vasculopathy.

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Cyclosporine Immunosuppression Does Not Prevent the Production of Donor-Specific Antibody Capable of Mediating Allograft Vasculopathy.

Bruton's Tyrosine Kinase Ablation Inhibits B Cell Responses and Antibody Production for the Prevention of Chronic Rejection in Cardiac Transplantation.

B Cells Mediate Chronic Allograft Rejection Independently of Antibody Production

Graft vasculopathy and tolerance: does the balance of Th cells contribute to graft vasculopathy?

Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection

Innate Immunity Alone is Not Sufficient for Chronic Rejection but Predisposes Healed Allografts to T Cell-Mediated Pathology.

Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.

THE ROLE OF B CELLS IN ANTI-CD45RB INDUCED TRANSPLANTATION TOLERANCE.:

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

Humoral Responses to Collagen-V and Vimentin Are Associated with Renal Graft Failure

Survival Time of Cardiac Allografts Prolonged by Isogeneic BMT in Mice.

Smooth muscle cells clonally expand in a murine carotid allograft model complicated by immune reactions to reporter transgenes

Abstract 12560: Single Cell RNA Sequencing Signature of Cardiac Allograft Vasculopathy

[Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule in cardiac allografts and significance thereof: experiment with rats]

Antibody-mediated Rejection in Human Cardiac Allografts: Histopathological and Immunohistochemical Study

Effects of Monoclonal Anti-T Cell Antibodies on Rat Cardiac Allografts

T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy